ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

NIH Alternative Medicine Officer Under Fire For Proposed RFA In Homeopathy, Acupuncture

February 26, 1993

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

Talpin To Join NCI

June 27, 2003

NIH Returns to Play Catch Up “After 16 Costly, Wasteful Days”

October 18, 2013

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

Concepts Approved For New Technology In Computers, Recompetition

November 6, 1987